There are notable differences between the functional regulatory mutations described here and those previously linked to TERT, ER, TAL1, MYC, and FOXA1. The latter are considered tumor-initiating events and activate bona fide drivers of oncogenesis. This evidence concerns the gene TERT and neoplasm.